Addressing the Challenges of Value Attribution ...

By HEOR Staff Writer

August 14, 2024

Introduction Combination therapies (CTs) are increasingly used in oncology to enhance clinical outcomes by merging treatments with differe...
Global Disparities in Pneumonia Vaccine Access
Health Economic Assessment of Nirsevimab for Respiratory Syncytial Virus in H...
Game-Changer in Atopic Dermatitis Care: Abrocitinib’s Cost-Effectivenes...
The Role of Real-World Evidence in CMS Price Negotiations
The Role of Pull Incentives in Addressing Antimicrobial Resistance
Cost-Utility and Cost-Effectiveness of Disease-Modifying Drugs for Relapsing-...
The Shift to Value-Based Drug Pricing in the United States
Cost Savings on Generic Drugs: Transparent Pricing Models
Quality-Adjusted Life Year (QALY) in Modern Healthcare Decision-Making
Strategies for Fair Drug Pricing: Balancing Pharmacy Viability and Cost Conta...
Sustainable Pricing in Diabetes: Cost-Effective Medication Access
Biosimilar Competition and Patient Out-of-Pocket Costs